# Adversarial Review Round 2

**Date:** 2026-08-28
**Focus:** Numerical Verification & Credibility
**Personas:** Accuracy Checker, Skeptical Expert

## Summary

| Severity | Count |
|----------|-------|
| FATAL | 0 |
| MAJOR | 0 |
| MINOR | 0 |

## Numerical Verification (Serena MCP Cross-Check)

### Primary Metrics

| Claim | Paper Value | Source File | Source Value | Verified |
|-------|-------------|-------------|--------------|----------|
| Cluster purity | 0.74 | h-e1/04_validation.md:13 | 0.7409 | ✅ |
| ARI | 0.31 | h-e1/04_validation.md:14 | 0.3128 | ✅ |
| NMI | 0.56 | h-e1/04_validation.md:15 | 0.5641 | ✅ |
| Linear probe | 29.21% | h-m1/04_validation.md:17 | 29.21% | ✅ |
| Overhead | 0.85x | h-m2/04_validation.md:20 | 0.848x | ✅ |
| F-statistic | 100.35 | h-m2/04_validation.md:43 | 100.355 | ✅ |
| TC-SSM accuracy | 51.49% | h-m3/04_validation.md:32 | 51.49% | ✅ |
| Baseline accuracy | 51.75% | h-m3/04_validation.md:33 | 51.75% | ✅ |
| Accuracy gap | 0.25% | h-m3/04_validation.md:34 | 0.25% | ✅ |
| Steps to 95% | 14 | h-m3/04_validation.md:35 | 14.0 | ✅ |

### Per-Task Results (16-shot)

| Task | Paper | h-m3 Source | Verified |
|------|-------|-------------|----------|
| BoolQ | 62.17% | 62.17% | ✅ |
| CB | 39.76% | 39.76% | ✅ |
| COPA | 53.67% | 53.67% | ✅ |
| RTE | 49.46% | 49.46% | ✅ |
| WiC | 51.20% | 51.20% | ✅ |

### Methodology Parameters

| Parameter | Paper | Source | Verified |
|-----------|-------|--------|----------|
| Base model | mamba-130m | ground_truth | ✅ |
| Teacher | bert-base-uncased | ground_truth | ✅ |
| K (clusters) | 8 | ground_truth | ✅ |
| Embedding dim | 32 | ground_truth | ✅ |
| Modulation rank | 32 | ground_truth | ✅ |
| Training steps | 2000 | ground_truth | ✅ |

## Credibility Assessment

| Check | Result |
|-------|--------|
| All numbers traceable to source | YES |
| Rounding within acceptable range | YES |
| Methodology matches implementation | YES |
| Baseline comparison fair | YES (after R1 fix) |

## Round 2 Verdict

**FATAL=0, MAJOR=0, MINOR=0**

All numerical claims verified against Phase 4 validation reports. No discrepancies found.
